Tags

Type your tag names separated by a space and hit enter

COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions.
JAMA. 2020 Jun 09; 323(22):2245-2246.JAMA

Links

Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

Kirkcaldy RD
US Centers for Disease Control and Prevention, Atlanta, Georgia.
King BA
US Centers for Disease Control and Prevention, Atlanta, Georgia.
Brooks JT
US Centers for Disease Control and Prevention, Atlanta, Georgia.

MeSH

Adaptive ImmunityAnimalsAntibodies, NeutralizingBetacoronavirusCOVID-19Coronavirus InfectionsHumansImmunoglobulin GMacacaPandemicsPneumonia, ViralRNA, ViralRecurrenceSARS-CoV-2

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32391855

Citation

Kirkcaldy, Robert D., et al. "COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions." JAMA, vol. 323, no. 22, 2020, pp. 2245-2246.
Kirkcaldy RD, King BA, Brooks JT. COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions. JAMA. 2020;323(22):2245-2246.
Kirkcaldy, R. D., King, B. A., & Brooks, J. T. (2020). COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions. JAMA, 323(22), 2245-2246. https://doi.org/10.1001/jama.2020.7869
Kirkcaldy RD, King BA, Brooks JT. COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions. JAMA. 2020 Jun 9;323(22):2245-2246. PubMed PMID: 32391855.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions. AU - Kirkcaldy,Robert D, AU - King,Brian A, AU - Brooks,John T, PY - 2020/5/12/pubmed PY - 2020/10/2/medline PY - 2020/5/12/entrez SP - 2245 EP - 2246 JF - JAMA JO - JAMA VL - 323 IS - 22 SN - 1538-3598 UR - https://www.unboundmedicine.com/medline/citation/32391855/full_citation L2 - https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.7869 DB - PRIME DP - Unbound Medicine ER -